Citeline leveraging Saama`s artificial intelligence to offer customers a complete understanding of the clinical trial landscape LONDON, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Today, Citeline, part of ...
The industry`s most comprehensive clinical trial data and analysis, now delivered to better fit customers` individual needs and workflows LONDON, June 19, 2017 (GLOBE NEWSWIRE) -- Informa Pharma ...
New collaboration integrates Citeline's comprehensive trial databases with Evinova's AI-native Study Designer to optimize decisions to improve study outcomes Evinova, a global health tech company with ...
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as “nice to have” but as a “must have.” ...
In March 2026, Citeline announced an expanded strategic partnership with Recursion Pharmaceuticals to integrate Citeline's real-world data and evidence into Recursion’s tech-enabled drug discovery and ...
Clinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Submitting clinical trial disclosures across different regions can be ...
NEW YORK and SALT LAKE CITY, March 31, 2026 (GLOBE NEWSWIRE) — Citeline, a leader in clinical solutions for the life sciences industry, today announced an expanded strategic partnership with Recursion ...
(MENAFN- GlobeNewsWire - Nasdaq) Clinical Trial Disclosure Solution Harmonizes Data Across Multiple Regions, Registries NEW YORK, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Submitting clinical trial ...
NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) -- With new Food and Drug Administration (FDA) guidance, study sponsors are no longer viewing clinical trial diversity as "nice to have" but as a "must have." ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results